USPH Earnings & Financial Statements
U.S. Physical Therapy, Inc.
$85.98
+$1.07(+1.26%)
65
Overall
80
Value
66
Tech
50
Quality
Market Cap
$1.27B
Volume
301.78K
52W Range
$58.19 - $93.50
Target Price
$97.00
USPH earnings and financial statements: U.S. Physical Therapy, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
USPH Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $780.99M | $671.35M | $604.80M | $553.14M | $495.02M |
| Cost of revenue | - | $547.42M | - | - | - |
| Operating income | $86.68M | $62.99M | $52.06M | $56.80M | $70.65M |
| EBITDA | $82.20M | $65.14M | $56.51M | $59.37M | $67.69M |
| Net income | $39.58M | $31.42M | $28.24M | $32.16M | $40.83M |
| EPS (diluted) | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.20B | $1.17B | $997.24M | $858.15M | $749.43M |
| Total liabilities | $433.81M | $408.42M | $345.00M | $373.59M | $296.98M |
| Shareholders’ equity | $476.43M | $488.93M | $476.19M | $315.79M | $295.61M |
| Cash and equivalents | $35.57M | $41.36M | $152.82M | $31.59M | $28.57M |
| Long-term debt | $263.17M | $244.40M | $215.64M | $253.76M | $191.77M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $75.06M | $74.94M | $81.98M | $58.54M | $76.41M |
| Capital expenditure | -$14.07M | -$9.19M | -$9.29M | -$8.25M | -$8.20M |
| Free cash flow | $60.99M | $65.75M | $72.68M | $50.29M | $68.20M |
| Dividends paid | $46.63M | $41.25M | $40.23M | $36.67M | $35.70M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | USPH | $85.98 | +1.3% | 301.78K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get U.S. Physical Therapy, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW